Vaccinex, Inc. Common Stock
VCNX
VCNX was delisted on the 17th of December, 2024.
18 hedge funds and large institutions have $1.05M invested in Vaccinex, Inc. Common Stock in 2020 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 4 closing their positions.
117% more call options, than puts
Call options by funds: $187K | Put options by funds: $86K
50% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 4
26% more capital invested
Capital invested by funds: $834K → $1.05M (+$219K)
25% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 4
13% more funds holding
Funds holding: 16 → 18 (+2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$82.4K |
| 2 |
Squarepoint
New York
|
+$80.8K |
| 3 |
Goldman Sachs
New York
|
+$70.3K |
| 4 |
OC
Oppenheimer & Co
New York
|
+$66.1K |
| 5 |
TI
Telemetry Investments
New York
|
+$35.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$81K |
| 2 |
WS
Wedbush Securities
Los Angeles,
California
|
-$55K |
| 3 |
VF
Virtu Financial
New York
|
-$47K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$35.1K |
| 5 |
Simplex Trading
Chicago,
Illinois
|
-$34.7K |
VCNX Hedge Fund Activity: Q4 2020 in Review
18 of the 5,676 institutional investors tracked by Wall St. Rank reported a position in Vaccinex, Inc. Common Stock (VCNX) for Q4 2020, worth a combined $1.05M — up 26% from $834K a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new VCNX positions and 4 closed out — a net gain of 2 holders — while 5 added to existing stakes and 4 trimmed.
The largest buyer was Vanguard Group, adding an estimated $82.4K. The largest seller was Qube Research & Technologies (QRT), exiting entirely with an estimated $81K sold.
- 18 institutional investors held Vaccinex, Inc. Common Stock (VCNX) as of Q4 2020, up from 16 in Q3 2020.
- Funds reported $1.05M of Vaccinex, Inc. Common Stock stock for Q4 2020, up 26% quarter-over-quarter.
- 6 funds opened new Vaccinex, Inc. Common Stock positions in Q4 2020 and 4 closed out, a net change of +2 holders.
- The largest Vaccinex, Inc. Common Stock buyer in Q4 2020 was Vanguard Group, an estimated $82.4K added.
- The largest Vaccinex, Inc. Common Stock seller in Q4 2020 was Qube Research & Technologies (QRT), an estimated $81K sold.
Based on aggregated 13F filings for Q4 2020.